The legal question presented in a Pfizer motion for partial summary judgment was whether a drugmaker, which "negligently or intentionally perpetrates a fraud upon the medical community" by the off-label marketing of its name-brand drug, can be held responsible for money paid to other drug companies that make the generic equivalent of the name-brand drug, wrote Philadelphia Common Pleas Judge Mark Bernstein.
Pharmalot » Pfizer On The Hook For Off-Label Generic Use
Posted by G00gle 895 days ago (http://www.pharmalot.com)Who Voted for this Story
Comments